Gabriel Ling - 18 Nov 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Gabriel Ling
Issuer symbol
TOI
Transactions as of
18 Nov 2025
Net transactions value
$0
Form type
4
Filing time
20 Nov 2025, 16:02:04 UTC
Previous filing
25 Nov 2024
Next filing
24 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ling Gabriel Director 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS /s/ Gabriel Ling 20 Nov 2025 0001945281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Other +141,149 +129% 250,206 18 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock of the Issuer received by the reporting person through an in-kind distribution by M33 Growth I, L.P. to its limited partners and on a pro rata basis in accordance with their pecuniary interests therein in reliance on Rules 16a-9 and 16a-13 under the Securities Exchange Act of 1934, as amended.